Skip to main content

Syndromic Gastric Polyps: At the Crossroads of Genetic and Environmental Cancer Predisposition

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 908))

Abstract

Gastric polyps occur in 1–4 % of patients undergoing gastroscopy. Although most are sporadic, some gastric polyps are part of an underlying hereditary syndrome. Gastric polyps can be seen in each of the well-known gastrointestinal polyposis syndromes, but also in Lynch syndrome and in several rare not primarily gastrointestinal syndromes. In addition, Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) is a recently described heritable syndrome characterized by isolated gastric polyposis and risk of gastric cancer.

Some of these syndromes are associated with an increased risk of gastric cancer, whereas others are not. However, the neoplastic potential and the precursor status of these gastric polyps are not always clear, even in syndromes with a well-established risk of gastric cancer. For instance, the neoplastic potential of Peutz–Jeghers polyps is debatable, despite the well-established risk of gastric cancer in this syndrome. Also fundic gland polyps and gastric foveolar-type adenomas in FAP carry a low risk of malignant transformation. In contrast, gastric juvenile polyps are precursor lesions of gastric cancer in juvenile polyposis syndrome through neoplastic progression of juvenile polyps in these patients.

Although these hereditary syndromes with gastric polyps are rare, recognition is important for individual patient management. Furthermore, the initiation and progression of these lesions can be influenced by environmental factors such as Helicobacter Pylori infection. This makes these rare lesions an appropriate model for understanding the clonal evolution of early gastric cancer in the wider population.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Carmack SW, Genta RM, Graham DY, et al. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009;6:331–41.

    Article  PubMed  Google Scholar 

  2. Carmack SW, Genta RM, Schuler CM, et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–32.

    Article  PubMed  Google Scholar 

  3. Gonzalez-Obeso E, Fujita H, Deshpande V, et al. Gastric hyperplastic polyps: a heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol. 2011;35:670–7.

    Article  PubMed  Google Scholar 

  4. Abraham SC, Singh VK, Yardley JH, et al. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25:500–7.

    Article  CAS  PubMed  Google Scholar 

  5. Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol. 2002;26:1276–85.

    Article  PubMed  Google Scholar 

  6. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J Clin Pathol. 2014;67:883–90.

    Article  PubMed  Google Scholar 

  7. Matsubara A, Sekine S, Kushima R, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol. 2013;229:579–87.

    Article  CAS  PubMed  Google Scholar 

  8. Wood LD, Salaria SN, Cruise MW, et al. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol. 2014;38:389–93.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lee SE, Kang SY, Cho J, et al. Pyloric gland adenoma in Lynch syndrome. Am J Surg Pathol. 2014;38:784–92.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lam-Himlin D, Park JY, Cornish TC, et al. Morphologic characterization of syndromic gastric polyps. Am J Surg Pathol. 2010;34:1656–62.

    PubMed  Google Scholar 

  11. Jansen M, Menko FH, Brosens LA, et al. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: present tense, future perfect? Gastrointest Endosc. 2014;80:1145–55.

    Article  PubMed  Google Scholar 

  12. Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–62.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nielsen M, Hes FJ, Nagengast FM, et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet. 2007;71:427–33.

    Article  CAS  PubMed  Google Scholar 

  14. Nielsen M, Morreau H, Vasen HF, et al. MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 2011;79:1–16.

    Article  PubMed  Google Scholar 

  15. Brosens LA, Keller JJ, Offerhaus GJ, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. 2005;54:1034–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6:180–5.

    Article  PubMed  Google Scholar 

  17. Attard TM, Cuffari C, Tajouri T, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004;99:681–6.

    Article  PubMed  Google Scholar 

  18. Torbenson M, Lee JH, Cruz-Correa M, et al. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002;15:718–23.

    Article  PubMed  Google Scholar 

  19. Abraham SC, Nobukawa B, Giardiello FM, et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol. 2001;158:1005–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Genta RM, Schuler CM, Robiou CI, et al. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7:849–54.

    Article  PubMed  Google Scholar 

  21. Zwick A, Munir M, Ryan CK, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology. 1997;113:659–63.

    Article  CAS  PubMed  Google Scholar 

  22. Arnason T, Liang WY, Alfaro E, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014;65:353–62.

    Article  PubMed  Google Scholar 

  23. Abraham SC, Nobukawa B, Giardiello FM, et al. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157:747–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Abraham SC, Park SJ, Mugartegui L, et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002;161:1735–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Park JY, Cornish TC, Lam-Himlin D, et al. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34:1591–8.

    PubMed  Google Scholar 

  26. Nakamura S, Matsumoto T, Kobori Y, et al. Impact of helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut. 2002;51:485–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102:1980–2.

    Article  CAS  PubMed  Google Scholar 

  28. Park JG, Park KJ, Ahn YO, et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum. 1992;35:996–8.

    Article  CAS  PubMed  Google Scholar 

  29. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993;217:101–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Leggett B. FAP: another indication to treat H pylori. Gut. 2002;51:463–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Boparai KS, Dekker E, Van Eeden S, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology. 2008;135:2014–8.

    Article  CAS  PubMed  Google Scholar 

  32. Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137:1976–85 e1-10.

    Article  CAS  PubMed  Google Scholar 

  33. Wiland H, Kalady H, Heald B, et al. Clinical and histopathologic characterization of polyp burden in patients with MUTYH-associated polyposis. Mod Pathol. 2015;28:198A.

    Google Scholar 

  34. Peltomäki PT, Offerhaus GJ, Vasen HFA. Lynch syndrome. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010.

    Google Scholar 

  35. Aarnio M, Salovaara R, Aaltonen LA, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer. 1997;74:551–5.

    Article  CAS  PubMed  Google Scholar 

  36. Capelle LG, Van Grieken NC, Lingsma HF, et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology. 2010;138:487–92.

    Article  PubMed  Google Scholar 

  37. Edelstein DL, Axilbund J, Baxter M, et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin Gastroenterol Hepatol. 2011;9:340–3.

    Article  PubMed  Google Scholar 

  38. Renkonen-Sinisalo L, Sipponen P, Aarnio M, et al. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol. 2002;37:574–7.

    Article  CAS  PubMed  Google Scholar 

  39. Brosens LA, van Hattem WA, Jansen M, et al. Gastrointestinal polyposis syndromes. Curr Mol Med. 2007;7:29–46.

    Article  CAS  PubMed  Google Scholar 

  40. McGarrity TJ, Kulin HE, Zaino RJ. Peutz-Jeghers syndrome. Am J Gastroenterol. 2000;95:596–604.

    Article  CAS  PubMed  Google Scholar 

  41. Tse JY, Wu S, Shinagare SA, et al. Peutz-Jeghers syndrome: a critical look at colonic Peutz-Jeghers polyps. Mod Pathol. 2013;26:1235–40.

    Article  PubMed  Google Scholar 

  42. van Lier MG, Westerman AM, Wagner A, et al. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut. 2011;60:141–7.

    Article  PubMed  Google Scholar 

  43. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53.

    Article  CAS  PubMed  Google Scholar 

  44. Jansen M, de Leng WW, Baas AF, et al. Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut. 2006;55:1–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Langeveld D, Jansen M, de Boer DV, et al. Aberrant intestinal stem cell lineage dynamics in Peutz-Jeghers syndrome and familial adenomatous polyposis consistent with protracted clonal evolution in the crypt. Gut. 2012;61:839–46.

    Article  CAS  PubMed  Google Scholar 

  46. Brosens LA, Langeveld D, van Hattem WA, et al. Juvenile polyposis syndrome. World J Gastroenterol. 2011;17:4839–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. van Hattem WA, Brosens LA, de Leng WW, et al. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut. 2008;57:623–7.

    Article  PubMed  Google Scholar 

  48. Delnatte C, Sanlaville D, Mougenot JF, et al. Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet. 2006;78:1066–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Menko FH, Kneepkens CM, de Leeuw N, et al. Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet. 2008;74:145–54.

    Article  CAS  PubMed  Google Scholar 

  50. Salviati L, Patricelli M, Guariso G, et al. Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy. Am J Hum Genet. 2006;79:593–6. author reply 596–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Brosens LA, van Hattem A, Hylind LM, et al. Risk of colorectal cancer in juvenile polyposis. Gut. 2007;56:965–7.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol. 1998;5:751–6.

    Article  CAS  PubMed  Google Scholar 

  53. Friedl W, Uhlhaas S, Schulmann K, et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet. 2002;111:108–11.

    Article  CAS  PubMed  Google Scholar 

  54. Aretz S, Stienen D, Uhlhaas S, et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet. 2007;44:702–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Jarvinen HJ, Sipponen P. Gastroduodenal polyps in familial adenomatous and juvenile polyposis. Endoscopy. 1986;18:230–4.

    Article  CAS  PubMed  Google Scholar 

  56. Ma C, Giardiello FM, Montgomery EA. Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation. Am J Surg Pathol. 2014;38:1618–26.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Postgate AJ, Will OC, Fraser CH, et al. Capsule endoscopy for the small bowel in juvenile polyposis syndrome: a case series. Endoscopy. 2009;41:1001–4.

    Article  CAS  PubMed  Google Scholar 

  58. Woodford-Richens K, Bevan S, Churchman M, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut. 2000;46:656–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Sayed MG, Ahmed AF, Ringold JR, et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol. 2002;9:901–6.

    Article  CAS  PubMed  Google Scholar 

  60. Handra-Luca A, Condroyer C, de Moncuit C, et al. Vessels’ morphology in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A. 2005;138:113–7.

    Article  Google Scholar 

  61. Hizawa K, Iida M, Yao T, et al. Juvenile polyposis of the stomach: clinicopathological features and its malignant potential. J Clin Pathol. 1997;50:771–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Langeveld D, van Hattem WA, de Leng WW, et al. SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clin Cancer Res. 2010;16:4126–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Pilarski R, Burt R, Kohlman W, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105:1607–16.

    Article  CAS  PubMed  Google Scholar 

  64. Heald B, Mester J, Rybicki L, et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology. 2010;139:1927–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Borowsky J, Setia N, Lauwers G, et al. Gastrointestinal tract pathology in PTEN hamartoma tumour syndrome: a review of 43 cases. Mod Pathol. 2015;28:149A.

    Google Scholar 

  66. Coriat R, Mozer M, Caux F, et al. Endoscopic findings in Cowden syndrome. Endoscopy. 2011;43:723–6.

    Article  CAS  PubMed  Google Scholar 

  67. Levi Z, Baris HN, Kedar I, et al. Upper and lower gastrointestinal findings in PTEN mutation-positive Cowden syndrome patients participating in an active surveillance program. Clin Transl Gastroenterol. 2011;2, e5.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Al-Thihli K, Palma L, Marcus V, et al. A case of Cowden’s syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol. 2009;6:184–9.

    Article  PubMed  Google Scholar 

  69. Hamby LS, Lee EY, Schwartz RW. Parathyroid adenoma and gastric carcinoma as manifestations of Cowden’s disease. Surgery. 1995;118:115–7.

    Article  CAS  PubMed  Google Scholar 

  70. Worthley DL, Phillips KD, Wayte N, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61:774–9.

    Article  CAS  PubMed  Google Scholar 

  71. Yanaru-Fujisawa R, Nakamura S, Moriyama T, et al. Familial fundic gland polyposis with gastric cancer. Gut. 2012;61:1103–4.

    Article  PubMed  Google Scholar 

  72. de Boer WB, Kumarasinghe M, Ee H. Gastric adenocarcinoma and proximal polyposis syndrome (GAPPS): not just fundic gland polyps. Mod Pathol. 2015;28:156A.

    Google Scholar 

  73. Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012;5:852–62.

    PubMed  PubMed Central  Google Scholar 

  74. Miettinen M, Fetsch JF, Sobin LH, et al. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30:90–6.

    Article  PubMed  Google Scholar 

  75. Agaimy A, Schaefer IM, Kotzina L, et al. Juvenile-like (inflammatory/hyperplastic) mucosal polyps of the gastrointestinal tract in neurofibromatosis type 1. Histopathology. 2014;64:777–86.

    Article  PubMed  Google Scholar 

  76. Durno CA, Holter S, Sherman PM, et al. The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. Am J Gastroenterol. 2010;105:2449–56.

    Article  CAS  PubMed  Google Scholar 

  77. Volkl TM, Dorr HG. McCune-Albright syndrome: clinical picture and natural history in children and adolescents. J Pediatr Endocrinol Metab. 2006;19 Suppl 2:551–9.

    PubMed  Google Scholar 

  78. Zacharin M, Bajpai A, Chow CW, et al. Gastrointestinal polyps in McCune Albright syndrome. J Med Genet. 2011;48:458–61.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Bhaijee F, Pittman M, Robertson S, et al. Upper gastrointestinal polyps in McCune Albright syndrome. Mod Pathol. 2015;28:148A.

    Google Scholar 

  80. Parvanescu A, Cros J, Ronot M, et al. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: GNAS-activating mutations in pancreatic carcinogenesis. JAMA Surg. 2014;149:858–62.

    Article  PubMed  Google Scholar 

  81. Slavik T, Montgomery EA. Cronkhite-Canada syndrome six decades on: the many faces of an enigmatic disease. J Clin Pathol. 2014;67:891–7.

    Article  PubMed  Google Scholar 

  82. Daniel ES, Ludwig SL, Lewin KJ, et al. The Cronkhite-Canada syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine. 1982;61:293–309.

    Article  CAS  PubMed  Google Scholar 

  83. Bettington M, Brown IS, Kumarasinghe MP, et al. The challenging diagnosis of Cronkhite-Canada syndrome in the upper gastrointestinal tract: a series of 7 cases with clinical follow-up. Am J Surg Pathol. 2014;38:215–23.

    Article  PubMed  Google Scholar 

  84. Burke AP, Sobin LH. The pathology of Cronkhite-Canada polyps. A comparison to juvenile polyposis. Am J Surg Pathol. 1989;13:940–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lodewijk A. A. Brosens .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brosens, L.A.A., Giardiello, F.M., Offerhaus, G.J., Montgomery, E.A. (2016). Syndromic Gastric Polyps: At the Crossroads of Genetic and Environmental Cancer Predisposition. In: Jansen, M., Wright, N. (eds) Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Advances in Experimental Medicine and Biology, vol 908. Springer, Cham. https://doi.org/10.1007/978-3-319-41388-4_17

Download citation

Publish with us

Policies and ethics